Concord Biotech IPO ( Jhunjhunwala Backed ) – Should you invest?

Concord Biotech IPO (Jhunjhunwala Backed) – Should you invest or avoid

Jhunjhunwala backed, Concord Biotech is coming up with an IPO that would open for subscription on August 4, 2023. Concord Biotech is a prominent India-based biopharma company with a strong global presence. Its core focus lies in the development and manufacturing of fermentation-based APIs (Active Pharmaceutical Ingredients) in the areas of immunosuppressants and oncology. Should you invest in Concord Biotech […]

» Read more